[Notice: The deadline for the grant listing below has expired. As a result, the information may no longer be accurate and additional research may be required. For current grant opportunities, please check out more recent issues of Funding Alert or the GrantStation database.]
DescriptionThe Company, a global leader in the protein biotherapeutics industry, offers Local Empowerment for Advocacy Development (LEAD) grants. The grants help improve the quality of life for people with rare disease who utilize plasma-derived or recombinant therapies for bleeding disorders, immune disorders, Alpha-1 deficiencies, or other conditions. The Company partners with patient organizations to address important public policy issues and grants are awarded twice annually to help patient organizations achieve their advocacy objectives. They can be used to further an existing advocacy initiative, provide assistance in developing a new initiative, build a grassroots database, and other projects. Applicants must be currently addressing a specific advocacy issue or intending to address such an issue. An online application is available along with other information on the Company’s Web site. Applications are due October 31 and April 30.
Contact information and additional details are available to members of the Society.
Funding Alert is intended to highlight key grant opportunities for nonprofit leaders with limited time for research. For a more comprehensive database of grants, the Society is also proud to provide all of our members will full access to GrantStation. GrantStation includes a database of over 5,000 current grant opportunities and other resources designed for grant professionals.
Join Now Login